By [ad_1]
Cipla commenced the Class II recall in the U.S. on Sept. 30, 2022. As per USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
[ad_2]
Source link
What is your reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0
